Intranasal Vaccine Formulation: Advancing Towards Nasal Dry Powder Formulation

• Egile Nagusiak: Kelvin Opoku Forkuoh (Egilea), Laura Urbano (Egilea), Laxmi Kerai-Varsani (Egilea), Darragh Murnane (Egilea)
• Formatua: Liburua
• Argitaratua: University of Huddersfield Press, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Unlike conventional mRNA vaccines, intranasal vaccines display several advantages, including the ability to generate strong mucosal immunity. However, the formulation challenges associated with intranasal mRNA vaccines have so far hindered their extensive application and further research in the area...